Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 14 May 2026 for Capricor Therapeutics, INC., €4,671.
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Frank Litvack: trading record in brief
This profile gathers the share dealings of Frank Litvack across 2 companies, led by Conor Medsystems Inc and Capricor Therapeutics, Inc. The record holds 23 filings, for trades running from 27 February 2006 to 13 May 2026.
Every open-market trade on record is a sale: 5 sales worth €2.4M. Besides market trades, the filings include 5 share grants and 6 option exercises.
The newest entry dates from 14 May 2026: an option exercise of €4,671, in Capricor Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Frank Litvack
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
3,937 shares@ US$1.390.0013% mcap1.2% of flowCommon StockSEC:0001310715-26-000004:0
25,000 shares@ US$1.396.9% of flowCommon StockSEC:0001415889-25-006736:0
20,391 shares@ US$1.104.4% of flowCommon StockSEC:0001415889-24-028337:0
20,748 shares@ US$1.395.4% of flowCommon StockSEC:0001415889-23-012326:0
14,027 shares@ US$1.393.8% of flowCommon StockSEC:0001415889-23-003083:0
154,543 shares@ US$1.3964.5% of flowCommon StockSEC:0001415889-22-000284:0
6 of 6 declarations
